Mono and dinuclear complexes as anticancer therapeutic leads

Last updated 18th Sep 2017
Follow pinboard


A pinboard by Paul Jarman

Postdoctoral researcher, University of Sheffield


Investigating the mechanism and ability of new anticancer drugs to overcome existing drug resistance

The inherent or acquired resistance of cancerous tumours to a leading chemotherapeutic drug, cisplatin, reduces or inhibits the effectiveness of this therapy and leads to a bleak prognosis for surv...